TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024
TFF Pharmaceuticals, Inc. (TFFP)
Company Research
Source: GlobeNewswire
FORT WORTH, Texas, March 14, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that Harlan Weisman, M.D., Chief Executive Officer of TFF Pharmaceuticals will be presenting a corporate overview at the 36th Annual Roth Conference being held March 17-19, 2024 in Dana Point, California. Company management will also be participating in one-on-one meetings. 36th Annual Roth Conference – March 17-19, 2024 Format: TFF Pharmaceuticals, Inc. Company PresentationDate/Time: Monday, March 18, 2024, at 11:30 am PTParticipant: Harlan Weisman, M.D., Chief Executive OfficerLocation: Dana Point, CaliforniaLink: Register here A replay of the presentation will be available through the registration link for 90 days. Please contact your Roth representative to schedule one-on-one meetings with the
Show less
Read more
Impact Snapshot
Event Time:
TFFP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TFFP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TFFP alerts
High impacting TFF Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
TFFP
News
- TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering [Yahoo! Finance]Yahoo! Finance
- TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public OfferingGlobeNewswire
- TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering [Yahoo! Finance]Yahoo! Finance
- TFF Pharmaceuticals Announces Pricing of $4.8 Million Public OfferingGlobeNewswire
- TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting [Yahoo! Finance]Yahoo! Finance
TFFP
Earnings
- 11/14/23 - Beat
TFFP
Sec Filings
- 5/2/24 - Form 8-K
- 5/1/24 - Form 424B4
- 4/30/24 - Form EFFECT
- TFFP's page on the SEC website